​

Stryker (SYK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SYK Stock Forecast

Stryker stock forecast is as follows: an average price target of $408.33 (represents a 10.12% upside from SYK’s last price of $370.81) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.

SYK Price Target

The average price target for Stryker (SYK) is $408.33 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $445.00 to $380.00. This represents a potential 10.12% upside from SYK's last price of $370.81.

SYK Analyst Ratings

Buy

According to 18 Wall Street analysts, Stryker's rating consensus is 'Buy'. The analyst rating breakdown for SYK stock is 0 'Strong Buy' (0.00%), 15 'Buy' (83.33%), 3 'Hold' (16.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Stryker Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Patrick WoodMorgan Stanley$445.00$390.9013.84%20.01%
Oct 31, 2024Joanne WuenschCitigroup$411.00$363.4313.09%10.84%
Oct 30, 2024Matt O'BrienPiper Sandler$420.00$367.9514.15%13.27%
Oct 30, 2024Richard NewitterTruist Financial$380.00$365.423.99%2.48%
Oct 30, 2024Kyle RoseCanaccord Genuity$400.00$359.0111.42%7.87%
Oct 30, 2024Ryan ZimmermanBTIG$394.00$359.019.75%6.25%
Oct 14, 2024Richard NewitterTruist Financial$370.00$356.453.80%-0.22%
Sep 10, 2024Matt O\'BrienPiper Sandler$380.00$365.224.05%2.48%
Aug 28, 2024Ryan ZimmermanBTIG$374.00$358.514.32%0.86%
Aug 01, 2024Richard NewitterTruist Financial$345.00$327.005.50%-6.96%
Jul 31, 2024Ryan ZimmermanBTIG$360.00$330.229.02%-2.92%
May 30, 2024David RomanGoldman Sachs$372.00$341.149.05%0.32%
May 22, 2024David ToungArgus Research$380.00$330.5114.97%2.48%
May 22, 2024Mike MatsonNeedham$392.00$330.5118.60%5.71%
Apr 15, 2024Ryan ZimmermanBTIG$366.00$342.057.00%-1.30%
Jan 31, 2023Matt O'BrienPiper Sandler$280.00$253.8110.32%-24.49%
Jan 06, 2023Morgan Stanley$260.00$254.931.99%-29.88%
Dec 21, 2022Ryan ZimmermanBTIG$268.00$239.6511.83%-27.73%
Dec 19, 2022Cowen CowenCowen & Co.$283.00$239.8418.00%-23.68%
Dec 02, 2022Barclays$257.00$238.767.64%-30.69%
Sep 24, 2022Matt O’BrienPiper Sandler$260.00$206.9325.65%-29.88%
Sep 06, 2022BTIG$238.00$202.6117.46%-35.82%
Jul 18, 2022BTIG$244.00$192.9126.48%-34.20%
Jul 18, 2022Stifel Nicolaus$245.00$193.2526.78%-33.93%
May 23, 2022David ToungArgus Research$270.00$232.4116.17%-27.19%
May 03, 2022Richard NewitterTruist Financial$280.00$236.9718.16%-24.49%
May 02, 2022Morgan Stanley$270.00$236.9713.94%-27.19%
Apr 30, 2022Matt O’BrienPiper Sandler$290.00$241.2620.20%-21.79%
Apr 29, 2022Wells Fargo$286.00$246.6415.96%-22.87%
Apr 21, 2022Ryan ZimmermanBTIG$278.00$276.370.59%-25.03%
Apr 16, 2022Shagun SinghRBC Capital$272.00$261.703.94%-26.65%
Mar 19, 2022Lee HambrightBernstein$295.00$267.3410.35%-20.44%
Mar 03, 2022Travis SteedBank of America Securities$300.00$266.4712.58%-19.10%
Jan 28, 2022Ryan ZimmermanBTIG$273.00$247.7610.19%-26.38%
Jan 28, 2022Matthew TaylorUBS$267.00$247.767.77%-28.00%
Jan 28, 2022Danielle AntalffyLeerink Partners$285.00$247.7615.03%-23.14%
Jan 28, 2022Robbie MarcusJ.P. Morgan$265.00$247.766.96%-28.53%
Jan 27, 2022Matthew O'BrienPiper Sandler$315.00$244.7028.73%-15.05%
Jan 21, 2022Pito ChickeringDeutsche Bank$285.00$254.0312.19%-23.14%
Dec 09, 2021Rick Aristotle MunarrizMotley Fool$278.00$259.217.25%-25.03%
Dec 06, 2021Jason WittesLoop Capital Markets$305.00$253.1120.50%-17.75%
Jul 29, 2021David ToungArgus Research$320.00$267.1819.77%-13.70%
Jul 28, 2021Matt MiksicCredit Suisse$311.00$266.6816.62%-16.13%
Jul 28, 2021Kyle RoseCanaccord Genuity$290.00$266.688.74%-21.79%
Jul 28, 2021Josh JenningsCowen & Co.$305.00$266.6814.37%-17.75%
Jul 28, 2021Steven LichtmanOppenheimer$288.00$266.687.99%-22.33%

The latest Stryker stock forecast, released on Dec 02, 2024 by Patrick Wood from Morgan Stanley, set a price target of $445.00, which represents a 13.84% increase from the stock price at the time of the forecast ($390.90), and a 20.01% increase from SYK last price ($370.81).

Stryker Price Target by Period

1M3M12M
# Anlaysts1715
Avg Price Target$445.00$402.86$385.93
Last Closing Price$370.81$370.81$370.81
Upside/Downside20.01%8.64%4.08%

In the current month, the average price target of Stryker stock is $445.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 20.01% increase as opposed to Stryker's last price of $370.81. This month's average price target is up 10.46% compared to last quarter, and up 15.31% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024RBC CapitalOutperformOutperformHold
Dec 11, 2024CitigroupBuyBuyHold
Oct 31, 2024BarclaysOverweightOverweightHold
Oct 31, 2024CitigroupBuyBuyHold
Oct 30, 2024Piper SandlerOverweightOverweightHold
Oct 30, 2024UBSNeutralNeutralHold
Oct 30, 2024Canaccord GenuityBuyBuyHold
Oct 14, 2024Wolfe ResearchBuyBuyHold
Oct 14, 2024BTIGBuyBuyHold
Oct 01, 2024Evercore ISIOutperformOutperformHold
Sep 10, 2024Piper SandlerOverweightOverweightHold
Sep 09, 2024Wolfe ResearchOutperformInitialise
Aug 28, 2024UBSBuyBuyHold
Aug 28, 2024BTIGBuyBuyHold
Aug 01, 2024BarclaysOverweightOverweightHold
Jul 31, 2024UBSBuyBuyHold
Jul 15, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Jul 15, 2024BTIGBuyBuyHold
May 30, 2024Goldman SachsNeutralInitialise
May 22, 2024NeedhamHoldBuyUpgrade
May 22, 2024NeedhamHoldPositiveUpgrade
May 02, 2024BarclaysOverweightOverweightHold
Apr 15, 2024RBC CapitalOutperformOutperformHold
Apr 15, 2024BTIGBuyBuyHold
Apr 11, 2024Cowen & Co.BuyBuyHold
Apr 03, 2024Wells FargoBuyBuyHold
Apr 03, 2024CitigroupBuyBuyHold
Jan 31, 2024UBSUnderperformUnderperformHold
Jan 31, 2024Wells FargoBuyBuyHold
Jan 12, 2024UBSBuyBuyHold
Dec 22, 2023UBSBuyBuyHold
Sep 05, 2023Bank of America SecuritiesBuyUpgrade
May 02, 2023NeedhamHoldHoldHold
May 02, 2023Piper SandlerOverweightOverweightHold
May 02, 2023RBC CapitalOutperformOutperformHold
Jan 31, 2023Piper SandlerOverweightOverweightHold
Jan 09, 2023RBC CapitalSector PerformOutperformUpgrade
Jan 06, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Dec 02, 2022BarclaysOverweightOverweightHold
Sep 14, 2022Piper SandlerOverweightOverweightHold
Sep 06, 2022BTIGBuyBuyHold
Jul 28, 2022Edward JonesBuyUpgrade
Jul 27, 2022Piper SandlerOverweightOverweightHold
Jul 18, 2022BTIGBuyBuyHold
May 17, 2022CitigroupBuyBuyHold
May 02, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Apr 30, 2022Piper SandlerOverweightOverweightHold
Apr 29, 2022Wells FargoOverweightOverweightHold
Apr 21, 2022BTIGBuyBuyHold
Apr 15, 2022RBC CapitalSector PerformSector PerformHold
Mar 19, 2022BernsteinOutperformUpgrade
Dec 12, 2021Loop Capital MarketsBuyInitialise

Stryker's last stock rating was published by RBC Capital on Dec 11, 2024. The company gave SYK a "Outperform" rating, the same as its previous rate.

Stryker Financial Forecast

Stryker Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$5.82B$4.91B$5.00B$4.78B$5.20B$4.48B$4.49B$4.28B$4.70B$4.16B$4.29B$3.95B$4.26B$3.74B$2.76B$3.59B$4.13B$3.59B
Avg Forecast$7.42B$6.42B$6.35B$6.14B$6.86B$5.94B$5.89B$5.70B$6.36B$5.37B$5.40B$5.10B$5.60B$4.87B$4.83B$4.57B$4.96B$4.47B$4.53B$4.18B$4.65B$4.22B$4.14B$3.95B$4.33B$3.41B$2.59B$3.57B$4.11B$3.58B
High Forecast$7.54B$6.52B$6.45B$6.24B$6.97B$6.04B$5.98B$5.79B$6.49B$5.37B$5.40B$5.10B$5.69B$4.91B$4.90B$4.64B$5.04B$4.47B$4.53B$4.18B$4.65B$4.22B$4.14B$3.95B$4.33B$3.41B$2.59B$3.57B$4.11B$3.58B
Low Forecast$7.29B$6.31B$6.24B$6.04B$6.75B$5.84B$5.79B$5.59B$6.27B$5.37B$5.40B$5.10B$5.51B$4.81B$4.75B$4.49B$4.88B$4.47B$4.53B$4.18B$4.65B$4.22B$4.14B$3.95B$4.33B$3.41B$2.59B$3.57B$4.11B$3.58B
# Analysts99998881017158913168912778138891399988
Surprise %------------1.04%1.01%1.04%1.05%1.05%1.00%0.99%1.02%1.01%0.99%1.04%1.00%0.98%1.10%1.07%1.00%1.01%1.00%

Stryker's average Quarter revenue forecast for Mar 24 based on 9 analysts is $5.10B, with a low forecast of $5.10B, and a high forecast of $5.10B. SYK's average Quarter revenue forecast represents a -12.22% decrease compared to the company's last Quarter revenue of $5.82B (Dec 23).

Stryker EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts99998881017158913168912778138891399988
EBITDA------------$1.26B$931.00M$965.00M$992.00M$1.44B$1.05B$1.03B$717.00M$995.00M$730.00M$903.00M$643.00M$894.00M$978.00M$106.00M$788.00M$1.13B$775.00M
Avg Forecast$1.93B$1.67B$1.65B$1.60B$1.79B$1.55B$1.53B$1.48B$1.65B$1.40B$1.41B$752.09M$1.46B$1.27B$1.26B$683.71M$1.10B$1.04B$1.06B$621.56M$1.08B$985.38M$967.02M$662.39M$1.01B$795.66M$605.34M$718.06M$958.88M$835.12M
High Forecast$1.96B$1.70B$1.68B$1.62B$1.81B$1.57B$1.56B$1.51B$1.69B$1.40B$1.41B$902.50M$1.48B$1.28B$1.27B$820.46M$1.32B$1.04B$1.06B$745.87M$1.08B$985.38M$967.02M$794.86M$1.01B$795.66M$605.34M$861.67M$958.88M$835.12M
Low Forecast$1.90B$1.64B$1.62B$1.57B$1.76B$1.52B$1.51B$1.45B$1.63B$1.40B$1.41B$601.67M$1.43B$1.25B$1.23B$546.97M$878.82M$1.04B$1.06B$497.25M$1.08B$985.38M$967.02M$529.91M$1.01B$795.66M$605.34M$574.45M$958.88M$835.12M
Surprise %------------0.86%0.74%0.77%1.45%1.31%1.01%0.98%1.15%0.92%0.74%0.93%0.97%0.89%1.23%0.18%1.10%1.18%0.93%

9 analysts predict SYK's average Quarter EBITDA for Mar 24 to be $752.09M, with a high of $902.50M and a low of $601.67M. This is -40.17% lower than Stryker's previous annual EBITDA (Dec 23) of $1.26B.

Stryker Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts99998881017158913168912778138891399988
Net Income------------$1.14B$692.00M$738.00M$592.00M$563.00M$816.00M$656.00M$323.00M$662.00M$438.00M$592.00M$302.00M$568.00M$621.00M$-83.00M$493.00M$725.00M$466.00M
Avg Forecast$1.80B$1.36B$1.35B$1.23B$1.64B$1.24B$1.23B$1.10B$1.49B$1.07B$1.08B$386.82M$1.26B$938.83M$917.98M$351.66M$730.88M$847.46M$876.44M$319.69M$1.05B$877.36M$823.78M$311.11M$981.27M$543.01M$215.45M$449.24M$946.35M$732.83M
High Forecast$1.84B$1.39B$1.38B$1.25B$1.67B$1.26B$1.26B$1.21B$1.51B$1.07B$1.08B$464.19M$1.29B$957.76M$936.80M$421.99M$877.05M$847.46M$876.44M$383.62M$1.05B$877.36M$823.78M$373.33M$981.27M$543.01M$215.45M$539.09M$946.35M$732.83M
Low Forecast$1.77B$1.33B$1.32B$1.20B$1.60B$1.21B$1.21B$1.04B$1.49B$1.07B$1.08B$309.46M$1.23B$885.83M$897.94M$281.32M$584.70M$847.46M$876.44M$255.75M$1.05B$877.36M$823.78M$248.88M$981.27M$543.01M$215.45M$359.39M$946.35M$732.83M
Surprise %------------0.91%0.74%0.80%1.68%0.77%0.96%0.75%1.01%0.63%0.50%0.72%0.97%0.58%1.14%-0.39%1.10%0.77%0.64%

Stryker's average Quarter net income forecast for Mar 24 is $386.82M, with a range of $309.46M to $464.19M. SYK's average Quarter net income forecast represents a -66.16% decrease compared to the company's last Quarter net income of $1.14B (Dec 23).

Stryker SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts99998881017158913168912778138891399988
SG&A------------$1.94B$1.70B$1.71B$1.78B$1.75B$1.46B$1.54B$1.71B$1.75B$1.60B$1.50B$1.57B$1.56B$1.24B$1.23B$1.33B$1.38B$1.29B
Avg Forecast$2.67B$2.31B$2.28B$2.21B$2.47B$2.14B$2.12B$2.05B$2.29B$1.93B$1.94B$2.05B$2.01B$1.75B$1.73B$1.86B$1.93B$1.61B$1.64B$1.69B$1.68B$1.53B$1.50B$1.62B$1.56B$1.23B$937.51M$1.21B$1.49B$1.29B
High Forecast$2.71B$2.34B$2.32B$2.24B$2.51B$2.17B$2.15B$2.08B$2.33B$1.93B$1.94B$2.46B$2.04B$1.77B$1.76B$2.23B$2.31B$1.61B$1.64B$2.03B$1.68B$1.53B$1.50B$1.95B$1.56B$1.23B$937.51M$1.45B$1.49B$1.29B
Low Forecast$2.62B$2.27B$2.24B$2.17B$2.43B$2.10B$2.08B$2.01B$2.25B$1.93B$1.94B$1.64B$1.98B$1.73B$1.70B$1.49B$1.54B$1.61B$1.64B$1.35B$1.68B$1.53B$1.50B$1.30B$1.56B$1.23B$937.51M$969.56M$1.49B$1.29B
Surprise %------------0.96%0.97%0.98%0.96%0.91%0.90%0.94%1.01%1.04%1.05%1.00%0.97%1.00%1.01%1.31%1.10%0.93%1.00%

Stryker's average Quarter SG&A projection for Mar 24 is $2.05B, based on 9 Wall Street analysts, with a range of $1.64B to $2.46B. The forecast indicates a 5.51% rise compared to SYK last annual SG&A of $1.94B (Dec 23).

Stryker EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts99998881017158913168912778138891399988
EPS------------$3.01$1.82$1.94$1.56$1.48$2.16$1.73$0.86$1.75$1.17$1.57$0.80$1.51$1.66$-0.22$1.32$1.94$1.24
Avg Forecast$4.68$3.53$3.51$3.19$4.24$3.21$3.20$2.85$3.87$2.77$2.79$2.36$3.27$2.43$2.38$2.00$2.84$2.20$2.27$1.95$2.72$2.28$2.14$1.99$2.55$1.41$0.56$1.81$2.46$1.90
High Forecast$4.78$3.60$3.58$3.25$4.33$3.28$3.27$3.14$3.92$2.77$2.79$2.36$3.34$2.48$2.43$2.04$2.89$2.20$2.27$1.95$2.72$2.28$2.14$1.99$2.55$1.41$0.56$1.81$2.46$1.90
Low Forecast$4.58$3.45$3.43$3.12$4.15$3.14$3.13$2.69$3.85$2.77$2.79$2.36$3.20$2.30$2.33$1.96$2.77$2.20$2.27$1.95$2.72$2.28$2.14$1.99$2.55$1.41$0.56$1.81$2.46$1.90
Surprise %------------0.92%0.75%0.81%0.78%0.52%0.98%0.76%0.44%0.64%0.51%0.73%0.40%0.59%1.18%-0.39%0.73%0.79%0.65%

According to 9 Wall Street analysts, Stryker's projected average Quarter EPS for Mar 24 is $2.36, with a low estimate of $2.36 and a high estimate of $2.36. This represents a -21.74% decrease compared to SYK previous annual EPS of $3.01 (Dec 23).

Stryker Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
DXCMDexCom$77.80$104.5034.32%Buy
STESTERIS$209.51$262.5025.29%Buy
MDTMedtronic$81.37$95.4017.24%Hold
ZBHZimmer Biomet$108.06$121.7812.70%Hold
SYKStryker$370.81$408.3310.12%Buy
SNNSmith & Nephew$25.44$27.006.13%Buy
ABTAbbott Laboratories$113.29$120.096.00%Buy
ZIMVZimVie$13.95$14.503.94%Buy
EWEdwards Lifesciences$74.12$76.332.98%Buy

SYK Forecast FAQ

Is Stryker a good buy?

Yes, according to 18 Wall Street analysts, Stryker (SYK) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 15 'Buy' recommendations, accounting for 83.33% of SYK's total ratings.

What is SYK's price target?

Stryker (SYK) average price target is $408.33 with a range of $380 to $445, implying a 10.12% from its last price of $370.81. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Stryker stock go up soon?

According to Wall Street analysts' prediction for SYK stock, the company can go up by 10.12% (from the last price of $370.81 to the average price target of $408.33), up by 20.01% based on the highest stock price target, and up by 2.48% based on the lowest stock price target.

Can Stryker stock reach $600?

SYK's average twelve months analyst stock price target of $408.33 does not support the claim that Stryker can reach $600 in the near future.

What is Stryker's current price target trend?

1 Wall Street analyst forecast a $445 price target for Stryker (SYK) this month, up 20.01% from its last price of $370.81. Compared to the last 3 and 12 months, the average price target increased by 8.64% and increased by 4.08%, respectively.

What are Stryker's analysts' financial forecasts?

Stryker's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $24.4B (high $24.78B, low $23.97B), average EBITDA is $6.34B (high $6.44B, low $6.23B), average net income is $5.21B (high $5.4B, low $5.05B), average SG&A $8.77B (high $8.9B, low $8.61B), and average EPS is $13.5 (high $14.01, low $13.11). SYK's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $26.33B (high $26.74B, low $25.89B), average EBITDA is $6.85B (high $6.96B, low $6.73B), average net income is $5.75B (high $5.86B, low $5.62B), average SG&A $9.46B (high $9.61B, low $9.3B), and average EPS is $14.9 (high $15.21, low $14.58).

Did the SYK's actual financial results beat the analysts' financial forecasts?

Based on Stryker's last annual report (Dec 2022), the company's revenue was $18.45B, beating the average analysts forecast of $18.14B by 1.68%. Apple's EBITDA was $4.24B, beating the average prediction of $3.82B by 11.05%. The company's net income was $2.36B, missing the average estimation of $2.77B by -15.01%. Apple's SG&A was $6.46B, missing the average forecast of $6.87B by -6.03%. Lastly, the company's EPS was $6.23, missing the average prediction of $9.25 by -32.68%. In terms of the last quarterly report (Dec 2023), Stryker's revenue was $5.82B, beating the average analysts' forecast of $5.6B by 3.80%. The company's EBITDA was $1.26B, missing the average prediction of $1.46B by -13.72%. Stryker's net income was $1.14B, missing the average estimation of $1.26B by -9.31%. The company's SG&A was $1.94B, missing the average forecast of $2.01B by -3.57%. Lastly, the company's EPS was $3.01, missing the average prediction of $3.27 by -7.91%